Notable Initiations: La Jolla Pharmaceutical (LJPC), SolarCity (SCTY), HubSpot (HUBS), Geron (GERN), Lumber Liquidators (LL)

In a report published Tuesday, Oppenheimer analysts initiated coverage on La Jolla Pharmaceutical Co. (LJPC) with an ‘Outperform‘ rating and $43 price target. On valuation measures, La Jolla Pharmaceutical Co. shares currently have a PEG ratio of (0.66). EPS for the same period is ($2.00). Currently there are 3 analysts that rate LJPC a ‘Buy’. […] View the full post at: Notable Initiations: La Jolla Pharmaceutical (LJPC), SolarCity (SCTY), HubSpot (HUBS), Geron (GERN), Lumber Liquidators (LL) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.